Connecticut Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.29M | Sell |
2,892
-11
| -0.4% | -$4.9K | 0.06% | 129 |
|
|
2025
Q1 | $1.41M | Sell |
2,903
-45
| -2% | -$21.8K | 0.07% | 115 |
|
|
2024
Q4 | $1.19M | Buy |
2,948
+19
| +0.6% | +$7.65K | 0.06% | 118 |
|
|
2024
Q3 | $1.36M | Sell |
2,929
-19
| -0.6% | -$8.84K | 0.07% | 127 |
|
|
2024
Q2 | $1.38M | Buy |
2,948
+14
| +0.5% | +$6.56K | 0.07% | 121 |
|
|
2024
Q1 | $1.23M | Buy |
2,934
+53
| +2% | +$22.2K | 0.07% | 129 |
|
|
2023
Q4 | $1.17M | Buy |
+2,881
| New | +$1.17M | 0.07% | 129 |
|